Cannabidiol Protects Retinal Neurons by Preserving Glutamine Synthetase Activity in Diabetes

Overview

Journal Mol Vis

Specialties Cell Biology
Molecular Biology
Ophthalmology

Date 2010 Sep 1

PMID 20806080

Citations 11

Authors

A B El-Remessy

Y Khalifa

S Ola

A S Ibrahim

G I Liou

Affiliations

Soon will be listed here.

Abstract

Purpose: We have previously shown that non-psychotropic cannabidiol (CBD) protects retinal neurons in diabetic rats by inhibiting reactive oxygen species and blocking tyrosine nitration. Tyrosine nitration may inhibit glutamine synthetase (GS), causing glutamate accumulation and leading to further neuronal cell death. We propose to test the hypothesis that diabetes-induced glutamate accumulation in the retina is associated with tyrosine nitration of GS and that CBD treatment inhibits this process.

Methods: Sprague Dawley rats were made diabetic by streptozotocin injection and received either vehicle or CBD (10 mg/kg/2 days). After eight weeks, retinal cell death, Müller cell activation, GS tyrosine nitration, and GS activity were determined.

Results: Diabetes causes significant increases in retinal oxidative and nitrative stress compared with controls. These effects were associated with Müller cell activation and dysfunction as well as with impaired GS activity and tyrosine nitration of GS. Cannabidiol treatment reversed these effects. Retinal neuronal death was indicated by numerous terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL)-labeled cells in diabetic rats compared with untreated controls or CBD-treated rats.

Conclusions: These results suggest that diabetes-induced tyrosine nitration impairs GS activity and that CBD preserves GS activity and retinal neurons by blocking tyrosine nitration.

Citing Articles

The pharmacology and therapeutic role of cannabidiol in diabetes.

Zhang J, Lin C, Jin S, Wang H, Wang Y, Du X Exploration (Beijing). 2023; 3(5):20230047.

PMID: 37933286 PMC: 10582612. DOI: 10.1002/EXP.20230047.

Antioxidative and Anti-Inflammatory Properties of Cannabidiol.

Atalay S, Jarocka-Karpowicz I, Skrzydlewska E Antioxidants (Basel). 2019; 9(1).

PMID: 31881765 PMC: 7023045. DOI: 10.3390/antiox9010021.

Effects of Cannabidiol on Diabetes Outcomes and Chronic Cerebral Hypoperfusion Comorbidities in Middle-Aged Rats.

Santiago A, Mori M, Guimaraes F, Milani H, de Oliveira R Neurotox Res. 2018; 35(2):463-474.

PMID: 30430393 DOI: 10.1007/s12640-018-9972-5.

Cannabidiol Treatment Improves Endothelium-Dependent Vasorelaxation in Mesenteric Arteries of Zucker Diabetic Fatty Rats.

Wheal A, Jadoon K, Randall M, OSullivan S Front Pharmacol. 2017; 8:248.

PMID: 28572770 PMC: 5436470. DOI: 10.3389/fphar.2017.00248.

Rod photoreceptors express GPR55 in the adult vervet monkey retina.

Bouskila J, Javadi P, Casanova C, Ptito M, Bouchard J PLoS One. 2013; 8(11):e81080.

PMID: 24244730 PMC: 3828256. DOI: 10.1371/journal.pone.0081080.

References

Gorg B, Wettstein M, Metzger S, Schliess F, Haussinger D . Lipopolysaccharide-induced tyrosine nitration and inactivation of hepatic glutamine synthetase in the rat. Hepatology. 2005; 41(5):1065-73. DOI: 10.1002/hep.20662. View

Belgrave B, Bird K, Chesher G, Jackson D, Lubbe K, Starmer G . The effect of cannabidiol, alone and in combination with ethanol, on human performance. Psychopharmacology (Berl). 1979; 64(2):243-6. DOI: 10.1007/BF00496070. View

Ward M, Jobling A, Kalloniatis M, Fletcher E . Glutamate uptake in retinal glial cells during diabetes. Diabetologia. 2005; 48(2):351-60. DOI: 10.1007/s00125-004-1639-5. View

Marsicano G, Moosmann B, Hermann H, Lutz B, Behl C . Neuroprotective properties of cannabinoids against oxidative stress: role of the cannabinoid receptor CB1. J Neurochem. 2002; 80(3):448-56. DOI: 10.1046/j.0022-3042.2001.00716.x. View

El-Remessy A, Behzadian M, Abou-Mohamed G, Franklin T, Caldwell R, Caldwell R . Experimental diabetes causes breakdown of the blood-retina barrier by a mechanism involving tyrosine nitration and increases in expression of vascular endothelial growth factor and urokinase plasminogen activator receptor. Am J Pathol. 2003; 162(6):1995-2004. PMC: 1868147. DOI: 10.1016/S0002-9440(10)64332-5. View

Lieth E, LaNoue K, Antonetti D, Ratz M . Diabetes reduces glutamate oxidation and glutamine synthesis in the retina. The Penn State Retina Research Group. Exp Eye Res. 2000; 70(6):723-30. DOI: 10.1006/exer.2000.0840. View

Liou G, Auchampach J, Hillard C, Zhu G, Yousufzai B, Mian S . Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci. 2008; 49(12):5526-31. PMC: 2588644. DOI: 10.1167/iovs.08-2196. View

Kowluru R, Kowluru V, Xiong Y, Ho Y . Overexpression of mitochondrial superoxide dismutase in mice protects the retina from diabetes-induced oxidative stress. Free Radic Biol Med. 2006; 41(8):1191-6. DOI: 10.1016/j.freeradbiomed.2006.01.012. View

Madsen-Bouterse S, Mohammad G, Kowluru R . Glyceraldehyde-3-phosphate dehydrogenase in retinal microvasculature: implications for the development and progression of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2009; 51(3):1765-72. PMC: 3258980. DOI: 10.1167/iovs.09-4171. View

10.

Drel V, Pacher P, Ali T, Shin J, Julius U, El-Remessy A . Aldose reductase inhibitor fidarestat counteracts diabetes-associated cataract formation, retinal oxidative-nitrosative stress, glial activation, and apoptosis. Int J Mol Med. 2008; 21(6):667-76. PMC: 2527815. View

11.

Pishak M, Phillips A . Glucocorticoid stimulation of glutamine synthetase production in cultured rat glioma cells. J Neurochem. 1980; 34(4):866-72. DOI: 10.1111/j.1471-4159.1980.tb09659.x. View

12.

Obrosova I, Fathallah L, Greene D . Early changes in lipid peroxidation and antioxidative defense in diabetic rat retina: effect of DL-alpha-lipoic acid. Eur J Pharmacol. 2000; 398(1):139-46. DOI: 10.1016/s0014-2999(00)00286-7. View

13.

Cunha J, Carlini E, Pereira A, Ramos O, Pimentel C, Gagliardi R . Chronic administration of cannabidiol to healthy volunteers and epileptic patients. Pharmacology. 1980; 21(3):175-85. DOI: 10.1159/000137430. View

14.

Abdelsaid M, Pillai B, Matragoon S, Prakash R, Al-Shabrawey M, El-Remessy A . Early intervention of tyrosine nitration prevents vaso-obliteration and neovascularization in ischemic retinopathy. J Pharmacol Exp Ther. 2009; 332(1):125-34. DOI: 10.1124/jpet.109.157941. View

15.

Goureau O, Regnier-Ricard F, Courtois Y . Requirement for nitric oxide in retinal neuronal cell death induced by activated Müller glial cells. J Neurochem. 1999; 72(6):2506-15. DOI: 10.1046/j.1471-4159.1999.0722506.x. View

16.

Asnaghi V, Gerhardinger C, Hoehn T, Adeboje A, Lorenzi M . A role for the polyol pathway in the early neuroretinal apoptosis and glial changes induced by diabetes in the rat. Diabetes. 2003; 52(2):506-11. DOI: 10.2337/diabetes.52.2.506. View

17.

Ali T, El-Remessy A . Diabetic retinopathy: current management and experimental therapeutic targets. Pharmacotherapy. 2009; 29(2):182-92. DOI: 10.1592/phco.29.2.182. View

18.

Shen X, Xu G . Role of IL-1beta on the glutamine synthetase in retinal Müller cells under high glucose conditions. Curr Eye Res. 2009; 34(9):727-36. DOI: 10.1080/02713680903030875. View

19.

Shelton M, Kern T, Mieyal J . Glutaredoxin regulates nuclear factor kappa-B and intercellular adhesion molecule in Müller cells: model of diabetic retinopathy. J Biol Chem. 2007; 282(17):12467-74. DOI: 10.1074/jbc.M610863200. View

20.

Kowluru R, ENGERMAN R, Case G, Kern T . Retinal glutamate in diabetes and effect of antioxidants. Neurochem Int. 2001; 38(5):385-90. DOI: 10.1016/s0197-0186(00)00112-1. View